Search results for: NICE
Filter search results
OHE at Priorities 2016: Valuing Health at the End of Life and MCDA for Priority Setting
19 September 2016
OHE’s Koonal Shah presented findings from his review of public preferences regarding end of life treatments at the Priorities 2016 conference in Birmingham. Martina Garau chaired a session on MCDA…
Presentations and Posters from ISPOR Europe 2016
24 November 2016
ISPOR’s 19th Annual European Congress was held in Vienna, 29 October – 2 November 2016. Several members of the OHE team attended and contributed to the conference. This post contains…
Multi-criteria Decision Analysis (MCDA) to Support Healthcare Decisions: Opportunities, Challenges and Unresolved Questions
18 May 2017
Just published is a new book entitled “Multi-criteria Decision Analysis (MCDA) to Support Healthcare Decisions”. It features a chapter by OHE’s Martina Garau and Professor Nancy Devlin on opportunities and…
OHE at ISPOR Boston 2017: Presentations and Posters
4 July 2017
A selection of the posters and presentations delivered by OHE at the ISPOR 22nd Annual International Meeting in Boston, May 2017, are available below. Adrian Towse participated in an invited…
OHE at iHEA Boston 2017: Meet the Team
5 July 2017
The 2017 iHEA congress will be held in Boston, 7th-11th July 2017. Members of the OHE team will be attending and participating in the conference, and would welcome the opportunity…
Challenges in Valuing Temporary Health States for Economic Evaluation: A Review of Empirical Applications of the Chained Time Trade-Off Method
26 December 2017
A new paper titled “Challenges in Valuing Temporary Health States for Economic Evaluation: A Review of Empirical Applications of the Chained Time Trade-Off Method” has been published in Value in…
Valuing Health at the End of Life: A Review of Stated Preference Studies in the Social Sciences Literature
9 April 2018
…in England, where since 2009 NICE has adopted a supplementary policy in its technology appraisal programme that effectively applies a premium for life-extending end of life treatments. Public preferences have…
Progression-free Survival as a Surrogate Outcome for Overall Survival in Oncology
4 September 2018
When should progression-free survival be used as a surrogate for overall survival in oncology? A recent article in the International Journal of Technology Assessment in Health Care, co-authored by OHE…
End of Life Treatments, Societal Values, and ‘Overall’ Preference
12 February 2019
OHE’s Koonal Shah gave a presentation on societal values and the provision of end of life treatments at a Manchester Centre for Health Economics seminar. On 4th February, OHE’s Koonal…